[HTML][HTML] In Silico identification and in vitro validation of repurposed compounds targeting the RSV polymerase
Respiratory Syncytial Virus (RSV) is the top cause of infant hospitalization globally, with no
effective treatments available. Researchers have sought small molecules to target the RNA …
effective treatments available. Researchers have sought small molecules to target the RNA …
[HTML][HTML] In Silico Identification and In Vitro Validation of Repurposed Compounds Targeting the RSV Polymerase
E Xu, S Park, J Calderon, D Cao, B Liang - Microorganisms, 2023 - ncbi.nlm.nih.gov
Abstract Respiratory Syncytial Virus (RSV) is the top cause of infant hospitalization globally,
with no effective treatments available. Researchers have sought small molecules to target …
with no effective treatments available. Researchers have sought small molecules to target …
[PDF][PDF] In Silico Identification and In Vitro Validation of Repurposed Compounds Targeting the RSV Polymerase. Microorganisms 2023, 11, 1608
E Xu, S Park, J Calderon, D Cao, B Liang - 2023 - med.emory.edu
Respiratory Syncytial Virus (RSV) is the top cause of infant hospitalization globally, with no
effective treatments available. Researchers have sought small molecules to target the RNA …
effective treatments available. Researchers have sought small molecules to target the RNA …
In Silico Identification and In Vitro Validation of Repurposed Compounds Targeting the RSV Polymerase.
E Xu, S Park, J Calderon, D Cao, B Liang - Microorganisms, 2023 - europepmc.org
Abstract Respiratory Syncytial Virus (RSV) is the top cause of infant hospitalization globally,
with no effective treatments available. Researchers have sought small molecules to target …
with no effective treatments available. Researchers have sought small molecules to target …
In Silico Identification and In Vitro Validation of Repurposed Compounds Targeting the RSV Polymerase
E Xu, S Park, J Calderon, D Cao, B Liang - Microorganisms, 2023 - search.proquest.com
Abstract Respiratory Syncytial Virus (RSV) is the top cause of infant hospitalization globally,
with no effective treatments available. Researchers have sought small molecules to target …
with no effective treatments available. Researchers have sought small molecules to target …
In Silico Identification and In Vitro Validation of Repurposed Compounds Targeting the RSV Polymerase
E Xu, S Park, J Calderon, D Cao… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Respiratory Syncytial Virus (RSV) is the top cause of infant hospitalization globally, with no
effective treatments available. Researchers have sought small molecules to target the RNA …
effective treatments available. Researchers have sought small molecules to target the RNA …
In Silico Identification and In Vitro Validation of Repurposed Compounds Targeting the RSV Polymerase.
E Xu, S Park, J Calderon, D Cao, B Liang - Microorganisms, 2023 - search.ebscohost.com
Abstract Respiratory Syncytial Virus (RSV) is the top cause of infant hospitalization globally,
with no effective treatments available. Researchers have sought small molecules to target …
with no effective treatments available. Researchers have sought small molecules to target …
In Silico Identification and In Vitro Validation of Repurposed Compounds Targeting the RSV Polymerase.
E Xu, S Park, J Calderon, D Cao, B Liang - Microorganisms, 2023 - europepmc.org
Respiratory Syncytial Virus (RSV) is the top cause of infant hospitalization globally, with no
effective treatments available. Researchers have sought small molecules to target the RNA …
effective treatments available. Researchers have sought small molecules to target the RNA …